R.I. Senate passes bill requiring insurers to cover biomarker cancer testing

THE R.I. SENATE has passed a bill sponsored by Sen. Maryellen Goodwin, D-Providence, that requires all health insurance plans to cover biomarker testing for cancer. Pictured is the R.I. Statehouse. / PBN FILE PHOTO/ARTISTIC IMAGES
PROVIDENCE – Legislation requiring all Rhode Island health insurance plans to cover biomarker testing for cancer treatment has passed the R.I. Senate. Sponsored by Sen. Maryellen Goodwin, D-Providence, 2022-S 2201 mandates that every policy offered by health insurers and other health organizations provide the coverage by the beginning of 2023. “Biomarker testing can save lives.…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display